Abstract
We have with interest read the comments raised by Lake et al in the e-letter titled ‘Time to personalise the treatment of anti-MDA-5 associated lung disease’ to be published in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have